Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...

Synthego and Vita Therapeutics, Inc. today announced a licensing agreement to integrate Synthego's high-fidelity hfCas12Max CRISPR system into Vita's cell therapeutic programs. This nonexclusive ...

Synthego and Vita Therapeutics sign licensing agreement for high-fidelity nucleases designed for therapeutic applications, hfCas12Max CRISPR system: Redwood City, California Wedne ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $34.26, moving -1.81% from the previous trading session.

A longstanding mystery in Parkinson’s disease research has been why some individuals carrying pathogenic variants that ...